November 25, 2013

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study provides a rationale to test AZD3965 in patients with SCLC. Our results suggest that patients with tumors expressing MCT1 and lacking in MCT4 are most likely to respond.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Polański et al. (Mon,) studied this question.

synapsesocial.com/papers/69d6d7e98dca315383ed939d https://doi.org/https://doi.org/10.1158/1078-0432.ccr-13-2270

Preguntar a la IA

Me gusta

Guardar